Stock Institutional Ownership and Shareholders

SecurityILIU / Interleukin Genetics, Inc. (458738101)
CEOCarbeau Mark B
Institutional Owners2
Institutional Shares48,848,704
Outstanding Shares229,434,511 (as of 2017-03-31)
Institutional Value$ 38,000 USD

Interleukin Genetics, Inc. (OTC:ILIU) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 48,848,704 shares. Largest shareholders include Pyxis Innovations Inc, and Cpcm, Llc.



Interleukin Genetics, Inc. (OTC:ILIU) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-11-14 13F-HR CPCM, LLC 1,222,864 38
2017-08-04 SC 13D/A PYXIS INNOVATIONS INC 47,625,840 47,625,840 0.00
CUSIP: 458738101